The effects of drotrecogin alpha and meropenem treatment on the levels of cytokines in rats with sepsis.
Dogan
Nazim
N
Department of Anesthiology, Ataturk University, Erzurum, Turkey. nazdogan@atauni.edu.tr
Boy
Salih
S
Yildirim
Abdulkadir
A
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D015415:Biomarkers; D016207:Cytokines / Q000097:blood / Q000187:drug effects*; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D000077731:Meropenem; D011486:Protein C / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D018805:Sepsis / Q000188:drug therapy*; D016019:Survival Analysis; D013845:Thienamycins / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D015415:Biomarkers; D016207:Cytokines; D005343:Fibrinolytic Agents; D011486:Protein C; D011994:Recombinant Proteins; D013845:Thienamycins; D000077731:Meropenem; C421124:drotrecogin alfa activated